KLRC1 and invasive breast carcinoma: Comparison between healthy donor, benign mammary tumor, NCIS, and localized, locally advanced, and metastatic invasive breast cancer peripheral blood NK cells displayed progressively decreased expression of activating receptors NKp30, NKG2D, 2B4, DNAM-1, CD16, and NKp46, as well as increasing expression of inhibitory NKG2A and CD85j/LIR-1 (20).